Sanofi Was Mystery Bidder That Lost Reata to Biogen 

Tainted Medication Fears Spur US Defense Department to Seek Outside Testing

A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients

Elon Musk's Neuralink Raises $280 Million to Develop Brain Implants

Sage Tumbles as Depression Pill Approval Omits Major Disorder

Astellas Pharma Secures US FDA Approval for Izervay

AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing

Could Your Sunscreen Be Contributing to Beach Erosion?

China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US

Global Abortion Pill Provider Buys From Manufacturer With Shoddy Quality Record

Biogen to Buy Reata for $7.3 Billion in Rare-Disease Expansion

Trump, DeSantis Clash in Iowa at Crucial Moment in 2024 Race